IRCCS San Raffaele Institute

Improving the efficiency of cancer vaccines with adoptive T cell therapy approaches 1:33
Improving the efficiency of cancer vaccines with adoptive T cell therapy approaches
Chiara Bonini • 1 Apr 2022
Targeting WT1 peptides for TCR-based AML therapy 2:04
Targeting WT1 peptides for TCR-based AML therapy
Chiara Bonini • 1 Apr 2022
TCR redirected T cells for cancer therapy 1:46
TCR redirected T cells for cancer therapy
Chiara Bonini • 1 Apr 2022
CAR-Tregs for the treatment of systemic lupus erythematosus 3:06
CAR-Tregs for the treatment of systemic lupus erythematosus
Chiara Bonini • 22 Nov 2021
Genome editing to address challenges with adoptive T-cell therapy 3:02
Genome editing to address challenges with adoptive T-cell therapy
Chiara Bonini • 22 Nov 2021
TCR gene editing in cancer therapy 3:04
TCR gene editing in cancer therapy
Chiara Bonini • 22 Nov 2021
Developing novel TCR-based T cell products for cancer therapy 3:13
Developing novel TCR-based T cell products for cancer therapy
Chiara Bonini • 22 Nov 2021
The content of VJRegenMed is intended for healthcare professionals